Clinical trial
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in…
NCT00003941 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003941 |
|---|---|
| Title | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer |
| Official title | A Randomized Phase III Study of Sequential High-Dose Cisplatinum/Etoposide/Ifosfamide Plus Stem Cell Support Versus BEP in Patients With Poor Prognosis Germ Cell Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mediastinal Cancer, Metastatic Cancer, Testicular Germ Cell Tumor |
| Intervention type | Biological, Drug, Procedure |
| Interventions | bleomycin sulfate, filgrastim, cisplatin, etoposide, ifosfamide, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation |
| Enrollment | 222 |
| Start date | Apr 1, 1999 |
| Primary completion | Jun 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 24, 2012 |
| Countries | Austria, Belgium, Denmark, Germany, Italy, Netherlands, Norway, Poland, Slovakia, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: